Effects of Photobiomodulation With Two Wavelengths of 630 and 810 nm on Diabetic Neuropathy
Share
This randomized controlled trial evaluated the effects of photobiomodulation (PBM) using two different wavelengths on patients with diabetic peripheral neuropathy (DPN), a common complication of type 2 diabetes that causes pain, numbness, and reduced nerve function. The study aimed to determine whether PBM could improve symptoms and nerve-related outcomes.
Researchers compared treatment effects on neuropathy-related symptoms, functional outcomes, and nerve health. The findings showed that PBM significantly helped reduce pain intensity, improve sensory function, and enhance overall nerve-related recovery compared with baseline or control measures. PBM’s benefits were linked to improved circulation, anti-inflammatory effects, and stimulation of cellular repair processes.
The study also suggested that wavelength selection matters, as different light wavelengths may produce varying therapeutic responses in nerve tissue. PBM appeared to be a safe, non-invasive supportive treatment for managing diabetic neuropathy symptoms.
Key takeaway: PBM using targeted wavelengths showed promising results for reducing symptoms and improving function in diabetic peripheral neuropathy patients, suggesting it may be a useful adjunct therapy alongside standard diabetic care.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10423950/